Discontinued — last reported Q4 '20
Vertex Pharmaceuticals Finance Lease Interest Paid remained flat by 0.0% to $1.40M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 78.2%, from $6.43M to $1.40M. Over 2 years (FY 2023 to FY 2025), Finance Lease Interest Paid shows a downward trend with a -61.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase suggests higher reliance on lease-based financing or higher interest rates on existing lease obligations.
This represents the portion of finance lease payments allocated to interest expense over the lease term. It reflects the...
Standard across companies reporting under ASC 842 or IFRS 16 lease accounting standards.
is_cvx_finance_lease_interest_paid| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $38.40M | $25.70M | $5.60M |
| YoY Change | — | -33.1% | -78.2% |
We use cookies for analytics. See our Privacy and Cookie Policy.